Form 4: Director McGarity Acquires Klotho Neurosciences Options

Klotho Neurosciences Director Jon McGarity acquired 20,000 non-qualified stock options at an exercise price of $0.41, bringing his total direct beneficial ownership to 60,000 options.

Summary

• Jon McGarity, a Director of Klotho Neurosciences, Inc. (KLTO), acquired 20,000 non-qualified stock options.
• The transaction occurred on December 10, 2025.
• The exercise price for these options is $0.41 per share.
• The options are fully vested and immediately exercisable.
• The expiration date for these options is January 16, 2035.
• Following this transaction, McGarity directly beneficially owns a total of 60,000 derivative securities (options).

Sentiment

Score: 7

Explanation: The acquisition of options by a director generally indicates confidence in the company's future, as the options' value is tied to stock price appreciation. This is a positive signal, though not a direct financial performance indicator.

Positives

• A director increasing their stake in the company through option acquisition can signal confidence in the company's future prospects.
• The acquired options are fully vested and immediately exercisable, providing flexibility to the holder.

Risks

• The value of the options is tied to the future performance of Klotho Neurosciences' common stock; if the stock price does not rise above the exercise price of $0.41, the options may expire worthless.

Future Outlook

This Form 4 filing reports an insider transaction and does not contain forward-looking statements or guidance from the company regarding its future outlook.

Industry Context

This filing is a standard insider transaction report, indicating a director's personal investment decision. It does not provide broader industry context or trends.

Comparison to Industry Standards

• Insider option acquisitions are a common form of executive compensation and personal investment across industries.
• The exercise price of $0.41 per share for the options is specific to Klotho Neurosciences and cannot be directly compared to other companies without their specific stock prices and option grants.

Related Party Transactions

• The acquisition of company securities by a director (Jon McGarity) is a related party transaction.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal of confidence in the company's future prospects and potential stock price appreciation.

Key Dates

Recommendation

The acquisition of additional stock options by a director signals management confidence in the company's future prospects, as the options' value is directly tied to stock price appreciation. However, this single transaction, without accompanying financial results or strategic updates, is insufficient to change a fundamental investment thesis. Investors should 'hold' and monitor future company performance and additional insider activity.

Keywords

Klotho Neurosciences, KLTO, Form 4, Insider Trading, Stock Options, Director, Beneficial Ownership, Equity Acquisition